Andlauer Healthcare Group (TSE:AND – Get Free Report) had its price target dropped by equities researchers at Eight Capital from C$58.00 to C$51.00 in a research note issued on Friday, BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Eight Capital’s price objective suggests a potential upside of 21.89% from the stock’s previous close.
A number of other brokerages also recently weighed in on AND. Scotiabank dropped their target price on shares of Andlauer Healthcare Group from C$46.00 to C$45.00 and set a “sector perform” rating for the company in a research note on Friday. Royal Bank of Canada dropped their target price on shares of Andlauer Healthcare Group from C$43.00 to C$41.00 and set a “sector perform” rating for the company in a research note on Monday, May 6th. TD Securities dropped their target price on shares of Andlauer Healthcare Group from C$54.00 to C$52.00 and set a “buy” rating for the company in a research note on Monday, May 6th. CIBC dropped their target price on shares of Andlauer Healthcare Group from C$52.00 to C$50.00 and set an “outperform” rating for the company in a research note on Monday, May 6th. Finally, Stifel Nicolaus dropped their target price on shares of Andlauer Healthcare Group from C$55.00 to C$52.00 and set a “buy” rating for the company in a research note on Monday, May 6th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of C$48.57.
Andlauer Healthcare Group Price Performance
Andlauer Healthcare Group (TSE:AND – Get Free Report) last announced its earnings results on Thursday, May 2nd. The company reported C$0.35 earnings per share for the quarter, missing analysts’ consensus estimates of C$0.53 by C($0.18). Andlauer Healthcare Group had a return on equity of 13.82% and a net margin of 10.02%. The company had revenue of C$161.14 million during the quarter, compared to the consensus estimate of C$168.50 million. Research analysts forecast that Andlauer Healthcare Group will post 1.6396243 EPS for the current year.
Insider Buying and Selling
In other Andlauer Healthcare Group news, Director Ronald Martin Skelton sold 1,500 shares of the company’s stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of C$40.87, for a total value of C$61,309.95. 1.43% of the stock is currently owned by insiders.
About Andlauer Healthcare Group
Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.
Featured Articles
- Five stocks we like better than Andlauer Healthcare Group
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Should You Invest in Bitcoin? Pros and Cons
- What is a Stock Market Index and How Do You Use Them?
- Amazon Stock is Primed to Rebound Strongly After AI Bubble Bursts
- What is the Euro STOXX 50 Index?
- Shell Stock: Oil & Gas Giant Committed to Buybacks and Dividends
Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.